Epidemiological trends in stage IV colorectal cancer

[1]  J. Poggio,et al.  It’s Not About the Money: Continued Treatment and Survival Outcome Disparities in Minority Rectal Cancer Patients After Controlling for Socioeconomic Factors , 2022, Annals of Surgical Oncology.

[2]  A. Parikh,et al.  The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer , 2022, PloS one.

[3]  V. Heinemann,et al.  Age and metastasis - How age influences metastatic spread in cancer. Colorectal cancer as a model. , 2022, Cancer epidemiology.

[4]  M. Reberšek.  Gut microbiome and its role in colorectal cancer , 2021, BMC Cancer.

[5]  A. Parikh,et al.  Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States , 2021, PLoS medicine.

[6]  H. Lenz,et al.  Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931) , 2021, Cancer.

[7]  B. Thompson,et al.  Disparities in post-operative surveillance testing for metastatic recurrence among colorectal cancer survivors , 2021, Journal of Cancer Survivorship.

[8]  K. Phan,et al.  Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis , 2021, International Journal of Colorectal Disease.

[9]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[10]  A. Jazieh,et al.  The Outcome of Unscreened Population in Colorectal Cancer: The Impact of Sex and Other Determinants on Cancer Stage , 2020, Cancer management and research.

[11]  F. Giardiello,et al.  Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas , 2020, Familial cancer.

[12]  J. Mecklin,et al.  Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population‐based study , 2020, BJS open.

[13]  David A. Drew,et al.  Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction , 2020, JNCI cancer spectrum.

[14]  Chyke A Doubeni,et al.  Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies. , 2020, Gastroenterology.

[15]  Jun Yu,et al.  Gut microbiota in colorectal cancer: mechanisms of action and clinical applications , 2019, Nature Reviews Gastroenterology & Hepatology.

[16]  A. Jemal,et al.  Global patterns and trends in colorectal cancer incidence in young adults , 2019, Gut.

[17]  E. Giovannucci,et al.  Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies , 2019, Nature Reviews Gastroenterology & Hepatology.

[18]  U. Ladabaum,et al.  Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years, 1975-2015. , 2019, JAMA.

[19]  A. Jemal,et al.  Cancer statistics for African Americans, 2019 , 2019, CA: a cancer journal for clinicians.

[20]  M. Kaminski,et al.  Clinical stages of colorectal cancer diagnosed in obese and overweight individuals in the Polish Colonoscopy Screening Program , 2019, United European gastroenterology journal.

[21]  Bei Zhang,et al.  Comparisons of metastatic patterns of colorectal cancer among patients by age group: a population-based study , 2018, Aging.

[22]  A. Andrew,et al.  Risk Factors for Diagnosis of Colorectal Cancer at a Late Stage: a Population-Based Study , 2018, Journal of General Internal Medicine.

[23]  R. Steele,et al.  A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK , 2018, BMC Cancer.

[24]  B. Graubard,et al.  Patterns and Trends in Cancer Screening in the United States , 2018, Preventing chronic disease.

[25]  S. Coughlin,et al.  Evaluation of Colorectal Cancer Incidence Trends in the United States (2000–2014) , 2018, Journal of clinical medicine.

[26]  E. Giovannucci,et al.  Lifestyle after Colorectal Cancer Diagnosis in Relation to Survival and Recurrence: A Review of the Literature , 2017, Current Colorectal Cancer Reports.

[27]  J. Witte,et al.  Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[28]  Fangfang Guo,et al.  Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.

[29]  A. Jemal,et al.  Racial and Ethnic Disparities in Interval Colorectal Cancer Incidence: A Population-Based Cohort Study. , 2017, Annals of internal medicine.

[30]  J. Tabernero,et al.  Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  P. Goodfellow,et al.  Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer , 2017, JAMA oncology.

[32]  Tariq Ahmad Masoodi,et al.  MED12 is recurrently mutated in Middle Eastern colorectal cancer , 2017, Gut.

[33]  Aung Ko Win,et al.  Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study , 2016, International journal of cancer.

[34]  Jan Sundquist,et al.  Patterns of metastasis in colon and rectal cancer , 2016, Scientific Reports.

[35]  D. Chang,et al.  Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients , 2016, Medicine.

[36]  S. Hendren,et al.  Colorectal cancer outcomes and treatment patterns in patients too young for average‐risk screening , 2016, Cancer.

[37]  D. Sargent,et al.  Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients. , 2015, Journal of the National Cancer Institute.

[38]  Y Nancy You,et al.  High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  R. Yaeger,et al.  Impact of somatic mutations on patterns of metastasis in colorectal cancer. , 2015, Journal of gastrointestinal oncology.

[40]  Aung Ko Win,et al.  PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[41]  Mary R. Kwaan,et al.  Does Patient Rurality Predict Quality Colon Cancer Care?: A Population-Based Study , 2015, Diseases of the colon and rectum.

[42]  M. Adams,et al.  Novel recurrently mutated genes in African American colon cancers , 2015, Proceedings of the National Academy of Sciences.

[43]  T. Hansen,et al.  Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature , 2015, Acta oncologica.

[44]  S. Weingart,et al.  Disparities in evaluation of patients with rectal bleeding 40 years and older. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[45]  A. Jemal,et al.  Disparities in survival improvement for metastatic colorectal cancer by race/ethnicity and age in the United States , 2014, Cancer Causes & Control.

[46]  M. McCullough,et al.  Association between red and processed meat intake and mortality among colorectal cancer survivors. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  J. Meyerhardt,et al.  Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. , 2012, Journal of the National Cancer Institute.

[48]  K. Hemminki,et al.  Age‐ and time‐dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers , 2012, International journal of cancer.

[49]  Amy B. Knudsen,et al.  Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[50]  B. Das,et al.  Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma , 2012, The International journal of biological markers.

[51]  J. Morgan,et al.  Predictors of delayed-stage colorectal cancer: are we neglecting critical demographic information? , 2011, Annals of epidemiology.

[52]  P. Krijnen,et al.  Disparities in quality of care for colon cancer between hospitals in the Netherlands. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[53]  Adeyinka O Laiyemo,et al.  Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. , 2010, Journal of the National Cancer Institute.

[54]  J. Meyerhardt,et al.  Impact of smoking on patients with stage III colon cancer , 2010, Cancer.

[55]  D. Wickerham,et al.  Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. , 1999, Journal of the National Cancer Institute.